Oncogenic H-ras induces cyclin B1 expression in a p53-independent manner

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 508, Issue 1-2, 2002, Pages 49-58

  Santana, Carla ^a   Ortega, Enrique ^a   García Carrancá, Alejandro ^a,b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

Cyclin B1; DNA damage; G2 M checkpoint; H ras oncogene; p53 independent

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN B1; MESSENGER RNA; PHOSPHOTRANSFERASE; PROTEIN P53; RAS PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; ENZYME ACTIVITY; ENZYME ASSAY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE INDUCTION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; NULL ALLELE; ONCOGENE; ONCOGENE H RAS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN FUNCTION; REGULATORY MECHANISM; WART VIRUS;

CDC2 PROTEIN KINASE; COLONIC NEOPLASMS; CYCLIN B; DNA DAMAGE; DNA-BINDING PROTEINS; G2 PHASE; GENES, RAS; HELA CELLS; HUMANS; MITOSIS; ONCOGENE PROTEINS, VIRAL; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037206594     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(02)00172-0     Document Type: Article

References (56)

1. Norbury C., Nurse P. Animal cell cycles and their control. Annu. Rev. Biochem. 61:1992;441-470.
2. Lock R.B., Ross W.E. Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in chinese hamster ovary cells. Cancer Res. 50:1990;3761-3766.
3. Tsao Y.-P., D'Arpa P., Liu L.F. The involvement of active DNA synthesis in camptothecin-induced G2 arrest, altered regulation of p34cdc2/cyclin B1. Cancer Res. 52:1992;1823-1829.
4. O'Connor P.M., Ferris D.K., Pagano M., Draetta G., Pines J., Hunter T., Longo D.L., Kohn K.W. G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. J. Biol. Chem. 268:1993;8298-8308.
5. Tounekti O., Pron G., Belehradek J., Mir L.M. Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res. 53:1993;5462-5469.
6. Lock R.B. Inhibition of p34cdc2 kinase activation, p34cdc2 tyrosine dephosphorylation and mitotic progression in chinese hamster ovary cells exposed to etoposide. Cancer Res. 52:1992;1817-1822.
7. Muschel R.J., Zhang H.B., Iliakis G., Mckenna W.G. Cyclin B expression in HeLa cells during the G2 block induced by ionizing radiation. Cancer Res. 51:1991;5113-5117.
8. Muschel R.J., Zhang H.B., McKenna W.G. Differential effect of ionizing radiation on the expression of cyclin A and cyclin B in HeLa cells. Cancer Res. 53:1993;1128-1135.
9. Maity A., McKenna W.G., Muschel R.J. Evidence for post-transcriptional regulation of cyclin B1 mRNA in the cell cycle and following irradiation in HeLa cells. EMBO J. 14:1995;603-609.
10. Kao G.D., McKenna W.G., Maity A., Blank K., Muschel R.J. Cyclin B1 availability is a rate-limiting component of the radiation-induced G2 delay in HeLa cells. Cancer Res. 57:1997;753-758.
11. Jin P., Hardy S., Morgan D.O. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J. Cell. Biol. 141:1998;875-885.
12. Chang T.H.-T., Ray F.A., Thompson D.A., Schlegel R. Disregulation of mitotic checkpoints and regulatory proteins following acute expression of SV40 large T antigen in diploid human cells. Oncogene. 14:1997;2383-2393.
13. Thompson D.A., Belinsky G., Chang T.H.-T., Jones D.L., Schlegel R., Münger K. The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic chechpoints. Oncogene. 15:1997;3025-3035.
14. Agarwal M.L., Agarwal A., Taylor W.R., Stark G.R. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 92:1995;8493-8497.
15. Stewart N., Hicks G.G., Paraskevas F., Mowat M. Evidence for a second cell cycle block at G2/M by p53. Oncogene. 10:1995;109-115.
16. Chan T.A., Hermeking H., Lengauer C., Kinzier K.W., Vogelstein B. 14-3-3σ is required to prevent mitotic catastrophe after DNA damage. Nature. 401:1999;616-620.
17. Innocente S.A., Abrahamson J.L.A., Cogwell J.P., Lee J.M. p53 regulates a G2 checkpoint through cyclin B1. Proc. Natl. Acad. Sci. U.S.A. 96:1999;2147-2152.
18. Taylor W.R., DePrimo S.E., Agarwal A., Agarwal M.L., Schönthal A.H., Katula K.S., Stark G.R. Mechanisms of G2 arrest in response to overexpression of p53. Mol. Biol. Cell. 10:1999;3607-3622.
19. Paules R.S., Levedakou E.N., Wilson S.J., Innes C.L., Rhodes N., Tlsty T.D., Galloway D.A., Donehower L.A., Tainsky M.A., Kaufmann W.K. Defective G2 checkpoint function in cells from individual with familial cancer syndromes. Cancer Res. 55:1995;1763-1773.
20. Agapova L.S., Ivanov A.V., Sablina A.A., Kopnin P.B., Sokova O.I., Chumakov P.M., Kopnin B.P. p53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints. Oncogene. 18:1999;3135-3142.
21. Passalaris T.M., Benanti J.A., Gewin L., Kiyono T., Galloway D.A. The G2 checkpoint is maintained by redundant pathways. Mol. Cell. Biol. 19:1999;5872-5881.
22. Barbacid M. Ras genes. Annu. Rev. Biochem. 56:1987;779-827.
23. Moodie S.A., Willumsen B.M., Weber M.J., Wolfman A. Complexes of Ras-GTP with Raf-1 and mitogen-activated protein kinase kinase. Science. 260:1993;1658-1661.
24. Filmus J., Robles A.I., Shi W., Wong M.J., Colombo L.L., Conti C.J. Induction of cyclin D1 overexpression by activated ras. Oncogene. 9:1994;3627-3633.
25. Albanese C., Johnson J., Watanabe G., Eklund N., Vu D., Arnold A., Pestell R.G. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270:1995;23589-23597.
26. Barrett C.B., Schroetke R.M., VanderHoorn F.A., Nordeen S.K., Maller J.L. H-rasval12, thr59 activates S6 kinase and p34cdc2 kinase in Xenopus oocytes, evidence for c-mosxe-dependent and -independent pathways. Mol. Cell. Biol. 10:1990;310-315.
27. Daar Y., Nebrada A.R., Yew N., Sass P., Paules R., Santos E., Wigler V., Woude G.F. The ras oncoprotein and m-phase activity. Science. 253:1991;74-76.
28. Durkin J.P., Whitfield J.F. The viral K-ras gene must be expressed in the G2 phase if ts Kirsten sarcoma virus-infected NRK cells are to proliferate in serum-free medium. Mol. Cell. Biol. 7:1987;444-449.
29. Hirakawa T., Ruley E. Rescue of cells from ras oncogene-induced growth arrest by a second, complementing. Proc. Natl. Acad. Sci. U.S.A. 85:1988;1519-1523.
30. Ridley A.J., Paterson H.F., Noble M., Land H. Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J. 7:1988;1635-1645.
31. McKenna W.G., Iliakis G., Weiss M.C., Bernhard E.J., Muschel R.J. Increased G2 delaying radiation-resistant cells obtained by transformation of primary rat embryo cells with the oncogenes H-ras and v-myc. Radiat. Res. 125:1991;283-287.
32. McKenna W.G., Bernhard E.J., Markiewicz D.A., Rudolts M.S., Maity A., Muschel R.J. Regulation of radiation-induced apoptosis in oncogene-transfected fibroblasts, influence of H-ras on the G2 delay. Oncogene. 12:1996;237-245.
33. Miranda E.I., Santana C., Rojas E., Hernández S., Ostrosky-Wegman P., García-Carrancá A. Induced mitotic death of HeLa cells by abnormal expression of c-H-ras. Mut. Res. 349:1996;173-182.
34. Maity A., Hwang A., Janss A., Phillips P., McKenna W.G., Muschel R.J. Delayed cyclin B1 expression during the G2 arrest following DNA damage. Oncogene. 13:1996;1647-1657.
35. Lock R.B., Galperina O.V., Feldhoff R.C., Rhodes L.J. Concentration-dependent differences in the mechanisms by which caffeine potentates etoposide cytotoxicity in HeLa cells. Cancer Res. 54:1994;4933-4939.
36. Chang E.H., Furth M.E., Scolnick E.M., Lowy D.R. Tumorigenic transformation of mammalian cells induced by a normal gene homologous to the oncogene of Harvey murine sarcoma virus. Nature. 297:1982;479-483.
37. Katula K.S., Wright K.L., Paul H., Surman D.R., Nuckolls F.J., Smith J.W., Ting J.P.Y., Yates J., Cogswell J.P. Cyclin-dependent kinase activation and S-phase induction of the cyclin B1 gene are linked through the CCAAT elements. Cell Growth Differ. 8:1997;811-820.
38. Galang C.K., Der C.J., Hauser C.A. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-ets2 binding sites. Oncogene. 9:1994;2913-2921.
39. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
40. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
41. Lau C.C., Pardee A.B. Mechanism by which caffeine potentiates lethality of nitrogen mustard. Proc. Natl. Acad. Sci. U.S.A. 79:1982;2942-2946.
42. Medina-Martínez O., Vallejo V., Guido M.C., García-Carrancá A. Ha-ras oncogene-induced transcription of human papillomavirus type 18 E6 and E7 oncogenes. Mol. Carcinogen. 19:1997;83-90.
43. Palmero I., Pantoja C., Serrano M. p19ARF links the tumour suppressor p53 to Ras. Nature. 395:1998;125-126.
44. Ries S., Biederer C., Woods D., Shifman O., Shirasawa S., Sasazuki T., McMahon M., Oren M., McCormick F. Opposing effects of ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell. 103:2000;321-330.
45. Powell S.N., DeFrank J.S., Connell P., Eogan M., Preffer F., Dombkowski D., Tang W., Friend S. Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res. 55:1995;1643-1648.
46. Russell K.J., Wiens L.W., Demers W., Galloway D., Plon S.E., Groudine M. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells. Cancer Res. 55:1995;1639-1642.
47. Gabrielli B.G., Sarcevic B., Sinnamon J., Walker G., Castellano M., Xue-Qing W., Ellem K.A.O. A cyclin D-cdk4 activity required for G2 phase cell cycle progression is inhibited in ultraviolet radiation-induced G2 phase delay. J. Biol. Chem. 274:1999;13961-13969.
48. Hitomi M., Stacey D.W. Ras-dependent cell cycle commitment during G2 phase. FEBS Lett. 490:2001;123-131.
49. Coco-Martin J.M., Balkenende A., Verschoor T., Lallemand F., Michalides R. Cyclin D1 overexpression enhances radiation-induced apoptosis and radiosensitivity in a breast tumor cell line. Cancer Res. 59:1999;1134-1140.
50. Moro A., Zerfass K., Joswig S., Jansen-Duerr P. Effect of cyclins and cdks on the cyclin B1 promoter activation. Biochem. Mol. Biol. Int. 41:1997;919-924.
51. Lock R., Keeling P.K. Responses of HeLa and Chinese hamster ovary p34cdc2/cyclin B kinase in relation to cell cycle perturbations induced by etoposide. Int. J. Oncol. 3:1993;33-42.
52. Hoffman I., Clarke P.R., Marcote M.J., Karsenti E., Draetta G. Phosphorylation and activation of human cdc25C by cdc2-cyclin B and its involvement in the self-amplification of MPF at mitosis. EMBO J. 12:1993;53-63.
53. Lock R.B., Ross W.E. Possible role for p34cdc2 kinase in etoposide-induced cell death of Chinese hamster ovary cells. Cancer Res. 50:1990;3767-3771.
54. Lopez-Girona A., Furnari B., Mondeseret O., Russell P. Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature. 397:1999;172-175.
55. Karlsson C., Katich S., Hasting A., Hoffmann I., Jonathan P. Cdc25B and cdc25C differ markedly in their properties as initiators of mitosis. J. Cell Biol. 146:1999;573-583.
56. Gabrielli B.G., Clark J.M., McCormack A.K., Ellem K.A.O. Ultraviolet light-induced G2 phase cell cycle checkpoint blocks cdc25-dependent progression into mitosis. Oncogene. 15:1997;749-758.